Other herpesviruses: HHV-6, HHV-7, HHV-8, HSV-1 and -2, VZV

American Journal of Transplantation

Volumn 4, Issue 10 SUPPL., 2004, Pages 66-71

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ANTIVIRUS AGENT; CHICKENPOX VACCINE; CIDOFOVIR; FAMCICLOVIR; FOSCARNET; GANCICLOVIR; IMMUNOGLOBULIN; VALACICLOVIR;

BONE MARROW SUPPRESSION; CYTOMEGALOVIRUS; DIAGNOSTIC ACCURACY; ENCEPHALITIS; FEVER; GRAFT REJECTION; HEPATITIS; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HUMAN; HUMAN HERPESVIRUS 6; HUMAN HERPESVIRUS 7; HUMAN HERPESVIRUS 8; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; ORGAN TRANSPLANTATION; PNEUMONIA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SEROPREVALENCE; VARICELLA ZOSTER VIRUS; VIRUS INFECTION; VIRUS LATENCY; VIRUS REACTIVATION; VIRUS REPLICATION; HERPES SIMPLEX; KAPOSI SARCOMA; POSTOPERATIVE COMPLICATION; TRANSPLANTATION; VIROLOGY;

HERPES SIMPLEX; HERPESVIRUS 1, HUMAN; HERPESVIRUS 2, HUMAN; HERPESVIRUS 3, HUMAN; HERPESVIRUS 6, HUMAN; HERPESVIRUS 7, HUMAN; HERPESVIRUS 8, HUMAN; HUMANS; IMMUNOSUPPRESSION; POSTOPERATIVE COMPLICATIONS; ROSEOLOVIRUS INFECTIONS; SARCOMA, KAPOSI; TRANSPLANTATION;

EID: 16644380123     PISSN: 16006135     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (25)

1. Gnann JW Jr. Herpes simplex and varicella zoster virus infection after hemopoietic stem cell or solid organ transplantation. In:Bowden RA, Ljungman P, Paya CV, eds. Transplant Infections, 2nd Edn. Philadelphia: Lippincott, Williams & Wilkins, 2003:350-366.
2. Xu F, Schillinger JA, Sternberg MR et al. Seroprevalence and coinfection with herpes simplex virus type 1 and type 2 in the United States, 1988-94. J Infect Dis 2002; 185: 1019-1024.
3. Koneru B, Tzakis AG, DePuydt LE et al. Transmission of fatal herpes simplex infection through renal transplantation. Transplantation 1988; 45(3): 653-656.
4. Singh N, Dummer JS, Kusne S et al. Infections with cytomegalovirus and other herpesviruses in 121 liver transplant recipients: transmission by donated organ and the effect of OKT3 antibodies. J Infect Dis 1988; 158: 124-131.
5. Smyth RL, Higenbottam TW, Scott JP et al. Herpes simplex virus infection in heart-lung transplant recipients. Transplantation 1990; 49: 735-739.
6. Kusne S, Schwartz M, Breinig MK et al. Herpes simplex virus hepatitis after solid organ transplantation in adults. J Infect Dis 1991; 163: 1001-1007.
7. Lowance D, Neumayer HH, Legendre CM et al. Valacyclovir for the prevention of cytomegalovirus disease after renal transplantation. International Valacyclovir Cytomegalovirus Prophylaxis Transplantation Study Group. N Engl J Med 1999; 340: 1462-1470.
8. Gane E, Saliba F, Valdecasas GJ et al. Randomised trial of efficacy and safety of oral ganciclovir in the prevention of cytomegalovirus disease in liver-transplant recipients. The Oral Ganciclovir International Transplantation Study Group [corrected]. Lancet 1997; 350: 1729-1733.
9. Fall AJ, Aitchison JD, Krause A, Hasan A, Hamilton JR, Gould FK. Donor organ transmission of varicella zoster due to cardiac transplantation. Transplantation 2000; 70: 211-213.
10. Feldhoff CM, Balfour HH Jr, Simmons RL, Najarian JS, Mauer SM. Varicella in children with renal transplants. J Pediatr 1981; 98: 25-31.
11. McGregor RS, Zitelli BJ, Urbach AH, Malatack JJ, Gartner JC Jr. Varicella in pediatric orthotopic liver transplant recipients. Pediatrics 1989; 83: 255-261.
12. Parnham AP, Flexman JP, Saker BM, Thatcher GN. Primary varicella in adult renal transplant recipients: a report of three cases plus a review of the literature. Clin Transplant 1995; 9: 115-118.
13. Rothwell WS, Gloor JM, Morgenstern BZ, Milliner DS. Disseminated varicella infection in pediatric renal transplant recipients treated with mycophenolate mofetil. Transplantation 1999; 68: 158-161.
14. Pettersson E, Hovi T, Ahonen J et al. Prophylactic oral acyclovir after renal transplantation. Transplantation 1985; 39: 279-281.
15. Pettersson E, Eklund B, Hockerstedt K, Salmela K, Ahonen J. Acyclovir and renal transplantation. Scand J Infect Dis Suppl 1985; 47: 145-148.
16. Broyer M, Tete MJ, Guest G, Gagnadoux MF, Rouzioux C. Varicella and zoster in children after kidney transplantation. Long-term results of vaccination. Pediatrics 1997; 99: 35-39.
17. Donati M, Zuckerman M, Dhawan A et al. Response to varicella immunization in pediatric liver transplant recipients. Transplantation 2000; 70: 1401-1404.
18. Webb NJ, Fitzpatrick MM, Hughes DA et al. Immunisation against varicella in end stage and pre-end stage renal failure. Trans-Pennine Paediatr Nephrol Study Group Arch Dis Child 2000; 82: 141-143.
19. Hata A, Asanuma H, Rinki M et al. Use of an inactivated varicella vaccine in recipients of hematopoietic-cell transplants. N Engl J Med 2002; 347: 26-34.
20. Prevention of varicella. Update recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 1999; 48(RR-6): 1-5.
21. Lynfield R, Herrin JT, Rubin RH. Varicella in pediatric renal transplant recipients. Pediatrics 1992; 90(2 Part 1): 216-220.
22. American Academy of Pediatrics. Varicella zoster virus. In:Pickering LK, ed. 2000. Red Book: Report of the Committee on Infectious Diseases, 25th Edn. Elk Grove Village, IL. American Academy of Pediatrics, 2000.
23. Meyers JD, Wade JC, Mitchell CD et al. Multicenter collaborative trial of intravenous acyclovir for treatment of mucocutaneous herpes simplex virus infection in the immunocompromised host. Am J Med 1982; 73: 229-235.
24. Meyers JD, Wade JC, Shepp DH, Newton B. Acyclovir treatment of varicella-zoster virus infection in the compromised host. Transplantation 1984; 37: 571-574.
25. Tyring S, Belanger R, Bezwoda W, Ljungman P, Boon R, Saltzman RL. A randomized, double-blind trial of famciclovir versus acyclovir for the treatment of localized dermatomal herpes zoster in immunocompromised patients. Cancer Invest 2001; 19: 13-22.